Results from an early-stage study of Loxo Oncology Inc.'s targeted cancer therapy keep getting better, the company said at the American Society of Clinical Oncology meeting taking place this weekend in Chicago.
from Bloomberg https://ift.tt/2Jm5pjL
Subscribe to:
Post Comments (Atom)
Alex Hanna, DAIR's director of research explores AI's impact on communities
Karan Singh for BI; Courtesy of Alex Hanna Hanna is a former Google AI ethicist who worked alongside Timnit Gebru , who was fired from...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Stocks could crash nearly 50% and a recession might hit this year, B. Riley's Paul Dietrich said. Yuichiro Chino/Getty Images The S...
-
The benchmark S&P 500 index just logged its longest losing streak of 2023, per data from Refinitiv. Mario Tama / Getty US stocks...
No comments:
Post a Comment